Evidence map›Paper›PMID 30917611›Full record

ReviewGels (Basel, Switzerland)2019

Recent Progress in Photon Upconverting Gels.

Pankaj Bharmoria, Nobuhiro Yanai, Nobuo Kimizuka

Open access · goldAbstract readReview
In one paragraph

Review in Gels (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Photon Upconversion Hydrogels for 3D Optogenetics.Advanced functional materials · 2021
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Pankaj BharmoriaDepartment of Chemistry and Biochemistry, Graduate School of Engineering, Center for Molecular Systems (CMS), Kyushu University, 744 Moto-oka, Nishi-ku, Fukuoka 819-0395, Japan. pankajbharmoria@gmail.com.
Nobuhiro YanaiDepartment of Chemistry and Biochemistry, Graduate School of Engineering, Center for Molecular Systems (CMS), Kyushu University, 744 Moto-oka, Nishi-ku, Fukuoka 819-0395, Japan. yanai@mail.cstm.kyushu-u.ac.jp.
Nobuo KimizukaDepartment of Chemistry and Biochemistry, Graduate School of Engineering, Center for Molecular Systems (CMS), Kyushu University, 744 Moto-oka, Nishi-ku, Fukuoka 819-0395, Japan. n-kimi@mail.cstm.kyushu-u.ac.jp.
Kyushu University · JP

Funding

Japan Science and Technology Agency JPMJPR14KEJapan Society for the Promotion of Science JP16H06513Japan Society for the Promotion of Science JP17H04799
6 · The paper itself

Abstract

Recent progress in the development of gels showing triplet-triplet annihilation based photon upconversion (TTA-UC) is reviewed. Among the two families of upconverting gels reported, those display TTA-UC based on molecular diffusion show performances comparable to those in solutions, and the TTA-UC therein are affected by dissolved molecular oxygen. Meanwhile, air-stable TTA-UC is achieved in organogels and hydrogels by suitably accumulating TTA-UC chromophores which are stabilized by hydrogen bonding networks of the gelators. The unique feature of the air-stable upconverting gels is that the self-assembled nanostructures are protected from molecular oxygen dissolved in the microscopically interconnected solution phase. The presence of the bicontinuous structures formed by the upconverting fibrous nanoassemblies and the solution phase is utilized to design photochemical reaction systems induced by TTA-UC. Future challenges include in vivo applications of hydrogels showing near infrared-to-visible TTA-UC.

Indexed as

oxygen blockingphotoluminescencephoton upconversionself-assemblytriplet-triplet annihilation

Identifiers

PMID30917611
PMCPMC6473564
OpenAlexW2925038976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.